Nmo Spectrum Disorder
📧 Sign up to get email alerts when something new happens for Nmo Spectrum Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) [Phase 3]
Phase 3 trial evaluating satralizumab as add-on therapy for neuromyelitis optica and NMOSD completed with posted results.
-
CLINICAL_TRIALS withdrawal · 2019-11-20Clinical Trial Update: Autologous Transplant To End NMO Spectrum Disorder [Phase 2, Phase 3]
A clinical trial investigating autologous transplant for Neuromyelitis Optica spectrum disorders has been withdrawn at Phase 2/Phase 3.